Literature DB >> 22177732

Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome.

Luana Fianchi1, Giuseppe Leone, Brunella Posteraro, Maurizio Sanguinetti, Francesco Guidi, Caterina Giovanna Valentini, Maria Teresa Voso, Livio Pagano.   

Abstract

Infections are a major cause of morbidity and mortality in patients with myelodysplastic syndrome (MDS) due to quantitative and qualitative granulocytic defects. We evaluated the in vitro bactericidal and fungicidal activities of neutrophils isolated from MDS. With comparison to those from healthy individuals, MDS neutrophils following infection showed a significantly reduced killing activity against Escherichia coli at 8 (p=0.002), 24 (p<0.0001), 48 (p=0.0005), and 72 h (p=0.0264), against Lactococcus lactis at 24 (p=0.0002), 48 (p<0.0001), and 72 h (p<0.0001), and more against Candida albicans at 8 (p=0.0003), 24 (p<0.0001), 48 (p<0.0001), and 72 h (p<0.0001). Our data show that MDS neutrophils have an impaired microbicidal function, which might account for the high susceptibility to infections of MDS patients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22177732     DOI: 10.1016/j.leukres.2011.11.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Monocyte function in patients with myelodysplastic syndrome.

Authors:  Daniel A Pollyea; Brenna R Hedin; Brian P O'Connor; Scott Alper
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

Review 2.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

3.  Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.

Authors:  Romy Tober; Ulf Schnetzke; Maximilian Fleischmann; Olaposi Yomade; Karin Schrenk; Jakob Hammersen; Anita Glaser; Christian Thiede; Andreas Hochhaus; Sebastian Scholl
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-18       Impact factor: 4.553

4.  Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.

Authors:  Kathleen M Wesa; Susanna Cunningham-Rundles; Virginia M Klimek; Emily Vertosick; Marci I Coleton; K Simon Yeung; Hong Lin; Stephen Nimer; Barrie R Cassileth
Journal:  Cancer Immunol Immunother       Date:  2014-10-29       Impact factor: 6.968

5.  Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib.

Authors:  Lea Bornemann; Marc Schuster; Saskia Schmitz; Charlyn Sobczak; Clara Bessen; Simon F Merz; Karl-Heinz Jöckel; Thomas Haverkamp; Matthias Gunzer; Joachim R Göthert
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

6.  miR-34a induces neutrophil apoptosis by regulating Cdc42-WASP-Arp2/3 pathway-mediated F-actin remodeling and ROS production.

Authors:  Meiwan Cao; Baoling Peng; Huan Chen; Min Yang; Peiyu Chen; Liping Ye; Hongli Wang; Lu Ren; Jing Xie; Jingnan Zhu; Xiangye Xu; Wanfu Xu; Lanlan Geng; Sitang Gong
Journal:  Redox Rep       Date:  2022-12       Impact factor: 5.696

7.  Impairment of FOS mRNA stabilization following translation arrest in granulocytes from myelodysplastic syndrome patients.

Authors:  Xiaomin Feng; Yayoi Shikama; Tsutomu Shichishima; Hideyoshi Noji; Kazuhiko Ikeda; Kazuei Ogawa; Hideo Kimura; Yasuchika Takeishi; Junko Kimura
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

Review 8.  Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy.

Authors:  Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 3.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.